Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP)

Detailed price information for Roivant Sciences Ltd (ROIV-Q) from The Globe and Mail including charting and trades.
Insurancenewsnet.com

Lawyer's Protector Plan® (LPP) now offers Excess & Surplus lines insurance coverage

Lawyer's Protector Plan, a division of Protector Plans, Inc., a wholly-owned subsidiary of Brown & Brown, Inc., announced today that they have expanded their lawyers' professional liability insurance ...
Business Insider

Lawyer's Protector Plan® (LPP) Promotes Christina Casals Melia to Assistant Program Leader to Support Long Term Growth and Sustainability

TAMPA, Fla., July 17, 2018 /PRNewswire-PRWeb/ -- Lawyer's Protector Plan, a division of B&B Protector Plans, Inc., a wholly-owned subsidiary of Brown & Brown, Inc., is pleased to announce the ...

Roivant Sciences: Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP)

Lichen planopilaris (LPP) is a highly morbid inflammatory scalp disorder that causes generally irreversible scarring hair loss, often accompanied by profound pain, itch, and burning sensations; no FDA ...